Trastuzumab (International)
In the US, Trastuzumab (trastuzumab systemic) is a member of the drug class HER2 inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer and Salivary Gland Cancer.
US matches:
- Trastuzumab
- Trastuzumab and hyaluronidase-oysk
- Trastuzumab-anns
- Trastuzumab-dkst
- Trastuzumab-dttb
- Trastuzumab-pkrb
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XC03
CAS registry number (Chemical Abstracts Service)
0180288-69-1
Chemical Formula
C6470-H10012-N1726-O2013-S42
Therapeutic Categories
Antineoplastic agent
Biological response modifier, BRM
Immunomodulator
Anti-HER2 monoclonal antibody
Chemical Name
Immunoglobulin G1 (human-mouse monoclonal rhuMab HER2γ₁-chain antihuman p185c-erbB²receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer (WHO )
Foreign Names
- Trastuzumabum (Latin)
- Trastuzumab (German)
- Trastuzumab (French)
- Trastuzumab (Spanish)
Generic Names
- Trastuzumab (OS: BAN, USAN, DCF)
- Trastuzumab (Genetical Recombination) (OS: JAN)
- Anti-HER-2 monoclonal antibody (IS)
- MAB anti-HER-2 (IS)
- UNII-P188ANX8CK (IS)
- Trastuzumab Emtansine (OS: USAN)
- Trastuzumab Emtansine (Genetical Recombination) (OS: JAN)
- ado-Trastuzumab emtansine (IS)
- PRO 132365 (IS)
- T-DM 1 (IS)
- Trastuzumab-MCC-DM 1 (IS)
- UNII-SE2KH7T06F (IS)
Brand Names
- Herceptin
Chugai Pharmaceutical, Japan; F. Hoffmann-La Roche LTD, Serbia; Genentech, Georgia; Genentech, United States; Genentech Inc., Oman; Hoffmann La Roche, Kuwait; Hoffmann-La Roche, Canada; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Paraguay; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Taiwan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche Pharmaceutical, China; Roche Products, Australia; Roche Products, United Kingdom; Roche Registration, Netherlands; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Registration, Slovenia; Roche Uruguay, Uruguay - Herceptin 150mg
Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - Herceptin 440mg
Roche Pharma Schweiz, Switzerland - Herceptin 600mg
Abacus, Austria; Haemato Pharm, Austria; Orifarm, Austria; Roche, Hungary; Roche Registration, Austria - Herceptin 600mg/5ml
Roche, Luxembourg; Roche Pharma Schweiz, Switzerland - Herceptin SC
Productos Roche, Chile; Roche, New Zealand; Roche Products, Australia - Herceptin SC 600mg/5ml
Roche, Israel - Hertraz
Biocon, Georgia - Herzuma
Celltrion, Slovenia - Kadcyla
Productos Roche, Chile; Roche, Bosnia & Herzegowina; Roche, Cyprus; Roche, Croatia (Hrvatska); Roche, Poland; Roche, Turkey; Roche Farma, Peru; Roche Registration Limited, Iceland - Kadcyla 160mg
Roche, Hungary - Kanjinti
Amgen Europe, Netherlands; Amgen Europe, Slovenia - Ontruzant
Samsung Bioepis, Latvia; Samsung Bioepis UK, Netherlands - Perjeta-Herceptin [+ Pertuzumab]
Hoffmann-La Roche, Canada - Trastuzumab Baxter
Baxter, New Zealand - Zedora
Libbs, Brazil - Kadcyla
Chugai Pharmaceutical, Japan; DSM Pharmaceuticals, Georgia; F. Hoffmann-La Roche LTD, Serbia; Genentech, United States; Hoffmann-La Roche, Canada; Roche, Argentina; Roche, Belgium; Roche, Brazil; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Estonia; Roche, Spain; Roche, Finland; Roche, France; Roche, Hong Kong; Roche, Ireland; Roche, Israel; Roche, Lithuania; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Sweden; Roche Products, Australia; Roche Products, United Kingdom; Roche Registration, Netherlands; Roche Registration, Romania; Roche Registration Ltd, Greece; Roche Registration, Slovenia - Kadcyla 100mg
Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - Kadcyla 160mg
Orifarm, Austria; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - Trazimera
Pfizer, Netherlands
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.